Posts Tagged ‘obesity’

Will Policy Makers or Market Forces Lower GLP-1 Costs First?

March 28, 2024 — A new economic analysis in JAMA Network Open brings unsurprising news: manufacturing costs for GLP-1 agonists are a tiny fraction of the price for these important medicines. This is always the case for innovative prescription drugs that must recover billions of dollars of development costs in order to be profitable. The response from policy makers […]

Obesity Medicine Wasn’t Born Yesterday, Ya Know

March 27, 2024 — Much of the world is having a revelation. Stat News call is a revolution. So does Oprah. They are waking up to a very basic fact that we’ve been working with for decades now. Obesity is a chronic, treatable disease. Obesity medicine wasn’t born yesterday. But it has, at times, been lonely. Arthur Frank, a […]

Do Free School Meals Reduce Obesity Prevalence?

March 26, 2024 — Eight states have moved to provide nutritious meals at school for free to all students. A few simple reasons make it clear enough that this is a good idea. It reduces the stigma attached to receiving free school meals while improving food security for children from low-income families. Furthermore, nutrition quality goes up for all […]

In Defense of a Person’s Concern About Gaining Weight

March 25, 2024 — Weight neutral approaches to health and healthcare are the subject of well-deserved attention. The World Obesity Federation recently published a position statement on recognizing and reducing weight stigma. One of nine recommendations was to “engage in weight-neutral health promotion.” But what does this really mean? How should a healthcare provider respond to a patient’s concern […]

From Weight Loss to Obesity to Cardiorenal Metabolic Health

March 22, 2024 — A profound shift in the understanding of medicines that help with excessive or abnormal fat is underway. A few years ago, everybody thought of these in only one frame of reference – weight loss drugs. But that is changing now. Discourse about them is moving from weight loss to obesity treatment and even further, to […]

Opening Medicare to Semaglutide for Obesity and Heart Disease

March 22, 2024 — This is a striking change. Until now, the steadfast refusal of CMS to allow coverage of any obesity medicine by Medicare has been unwavering. Then two weeks ago, FDA granted a new indication for semaglutide for persons with both heart disease and obesity to prevent heart attacks, strokes, and deaths. Now CMS says it’s A-OK […]

Adding Up the Cost of Untreated Obesity in Pennsylvania

March 20, 2024 — There is a hot debate playing out in medical journals and editorials all over the country. How can we pay for the advanced obesity medicines for which people are expressing such a great need? What often gets lost in this discussion is the fact that we are already paying. Yesterday, we had the good fortune […]

Oprah Discovers Self-Stigma and the World Listens

March 19, 2024 — Celebrity weight loss is a bane to the world. For years, Oprah found herself sucked into it and, as a result, took on a lot of self-stigma. In an hour-long program on ABC last night, though, she shared her new awareness of this: “I have to say that I took on the shame that the […]

Lining Up at Amazon and LillyDirect for Obesity Medicines

March 18, 2024 — Hear that rumble? Nope, it not the latest SpaceX launch. It is the roar of growing demand for obesity care in the U.S. Two pieces of news in the last week remind us of how steep the upward line of growth in obesity treatment is right now. To help it scale up their reach to […]

Tripping Over the Relationship Between Obesity and PCOS

March 14, 2024 — Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting young women, with effects that can span from adolescence to life after menopause. It is a complex condition and despite being so common, it’s still poorly understood. Quite often, obesity occurs coincidentally with PCOS. This coincidence has led to the kind of mistakes that […]